Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Regulation of the nucleocytoplasmic trafficking of viral and cellular proteins by ubiquitin and small ubiquitin-related modifiers.

Wang YE, Pernet O, Lee B.

Biol Cell. 2012 Mar;104(3):121-38. doi: 10.1111/boc.201100105. Epub 2011 Dec 28. Review.

2.

Human pathogens and the host cell SUMOylation system.

Wimmer P, Schreiner S, Dobner T.

J Virol. 2012 Jan;86(2):642-54. doi: 10.1128/JVI.06227-11. Epub 2011 Nov 9. Review.

3.

Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth.

Kubo T, Shimose S, Matsuo T, Fujimori J, Sakaguchi T, Yamaki M, Shinozaki K, Woo SL, Ochi M.

J Orthop Res. 2011 May;29(5):795-800. doi: 10.1002/jor.21307. Epub 2010 Dec 17.

4.

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Cargnello M, Roux PP.

Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83. doi: 10.1128/MMBR.00031-10. Review. Erratum in: Microbiol Mol Biol Rev. 2012 Jun;76(2):496.

5.

The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions.

Keshet Y, Seger R.

Methods Mol Biol. 2010;661:3-38. doi: 10.1007/978-1-60761-795-2_1. Review.

PMID:
20811974
6.

The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells.

Lu YY, Chen TS, Wang XP, Qu JL, Chen M.

FEBS Lett. 2010 Sep 24;584(18):4019-26. doi: 10.1016/j.febslet.2010.08.014. Epub 2010 Aug 13.

7.

JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol.

Ceballos-Olvera I, Chávez-Salinas S, Medina F, Ludert JE, del Angel RM.

Virology. 2010 Jan 5;396(1):30-6. doi: 10.1016/j.virol.2009.10.019. Epub 2009 Nov 7.

8.

Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis.

Hu YB, Liu XY.

Scand J Gastroenterol. 2009;44(11):1356-62. doi: 10.3109/00365520903312441.

PMID:
19891587
9.

The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats.

Liu JR, Zhao Y, Patzer A, Staak N, Boehm R, Deuschl G, Culman J, Bonny C, Herdegen T, Eschenfelder C.

Neuropathol Appl Neurobiol. 2010 Apr;36(3):211-24. doi: 10.1111/j.1365-2990.2009.01047.x. Epub 2009 Oct 22.

PMID:
19849792
10.

Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.

Kluwe J, Pradere JP, Gwak GY, Mencin A, De Minicis S, Osterreicher CH, Colmenero J, Bataller R, Schwabe RF.

Gastroenterology. 2010 Jan;138(1):347-59. doi: 10.1053/j.gastro.2009.09.015. Epub 2009 Sep 24.

11.

Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection.

Isaacson MK, Ploegh HL.

Cell Host Microbe. 2009 Jun 18;5(6):559-70. doi: 10.1016/j.chom.2009.05.012. Review.

12.

Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.

Nagata H, Hatano E, Tada M, Murata M, Kitamura K, Asechi H, Narita M, Yanagida A, Tamaki N, Yagi S, Ikai I, Matsuzaki K, Uemoto S.

Hepatology. 2009 Jun;49(6):1944-53. doi: 10.1002/hep.22860.

PMID:
19418558
13.

JNK and p38 mitogen-activated protein kinase pathways contribute to porcine circovirus type 2 infection.

Wei L, Zhu Z, Wang J, Liu J.

J Virol. 2009 Jun;83(12):6039-47. doi: 10.1128/JVI.00135-09. Epub 2009 Apr 1.

14.

Beyond apoptosis of JNK1 in liver cancer.

Chen F, Castranova V.

Cell Cycle. 2009 Apr 15;8(8):1145-7. Epub 2009 Apr 16.

PMID:
19270500
15.

Echographic detection of diethylnitrosamine-induced liver tumors in rats and the effect of the intratumoral injection of an inhibitor of c-Jun N-terminal kinase.

Hanajiri K, Mitsui H, Maruyama T, Hashimoto N, Sata M, Omata M.

J Gastroenterol Hepatol. 2009 May;24(5):866-71. doi: 10.1111/j.1440-1746.2008.05722.x. Epub 2009 Feb 9.

PMID:
19220657
16.

Targeting the RAF-MEK-ERK pathway in cancer therapy.

Montagut C, Settleman J.

Cancer Lett. 2009 Oct 8;283(2):125-34. doi: 10.1016/j.canlet.2009.01.022. Epub 2009 Feb 12. Review.

PMID:
19217204
17.

JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

Mucha SR, Rizzani A, Gerbes AL, Camaj P, Thasler WE, Bruns CJ, Eichhorst ST, Gallmeier E, Kolligs FT, Göke B, De Toni EN.

Gut. 2009 May;58(5):688-98. doi: 10.1136/gut.2008.154625. Epub 2008 Dec 23.

PMID:
19106147
18.

Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.

Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF.

J Clin Invest. 2008 Dec;118(12):3943-53. doi: 10.1172/JCI37156. Epub 2008 Nov 6.

19.

Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats.

Altomonte J, Braren R, Schulz S, Marozin S, Rummeny EJ, Schmid RM, Ebert O.

Hepatology. 2008 Dec;48(6):1864-73. doi: 10.1002/hep.22546.

PMID:
19003878
20.

JNK signaling in apoptosis.

Dhanasekaran DN, Reddy EP.

Oncogene. 2008 Oct 20;27(48):6245-51. doi: 10.1038/onc.2008.301. Review.

Supplemental Content

Support Center